US Stock MarketDetailed Quotes

Crescent Biopharma (CBIO)

Watchlist
  • 18.550
  • -1.420-7.11%
Close May 18 15:59 ET
  • 18.550
  • 0.0000.00%
Post 16:10 ET
511.46MMarket Cap-3.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Crescent Biopharma (CBIO) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Research and development of its research programs, CR-001, CR-002, and CR-0031.04M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
China10.84M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +28.67%
Sample Name
Sample Code
 +23.05%
Sample Name
Sample Code
 +22.42%
4
United Sts Brent Oil Fd Lp Unit
BNO
+21.50%
5
ProShares Ultra Energy
DIG
+19.88%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +9.81%
Sample Name
Sample Code
 +5.47%
Sample Name
Sample Code
 +3.50%
4
Hesai
HSAI
+0.96%
5
MINISO
MNSO
-0.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -